HRP20170416T1 - Sintetski postupci i postupci pročišćavanja spojeva fosfaplatine i njihova uporaba - Google Patents

Sintetski postupci i postupci pročišćavanja spojeva fosfaplatine i njihova uporaba Download PDF

Info

Publication number
HRP20170416T1
HRP20170416T1 HRP20170416TT HRP20170416T HRP20170416T1 HR P20170416 T1 HRP20170416 T1 HR P20170416T1 HR P20170416T T HRP20170416T T HR P20170416TT HR P20170416 T HRP20170416 T HR P20170416T HR P20170416 T1 HRP20170416 T1 HR P20170416T1
Authority
HR
Croatia
Prior art keywords
platinum
reaction mixture
pyrophosphate
substituted
monomer complex
Prior art date
Application number
HRP20170416TT
Other languages
English (en)
Croatian (hr)
Inventor
Wayne D. Luke
Steffen Jost
Original Assignee
Phosplatin Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phosplatin Therapeutics Llc filed Critical Phosplatin Therapeutics Llc
Publication of HRP20170416T1 publication Critical patent/HRP20170416T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HRP20170416TT 2012-05-24 2013-03-15 Sintetski postupci i postupci pročišćavanja spojeva fosfaplatine i njihova uporaba HRP20170416T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261651200P 2012-05-24 2012-05-24
PCT/US2013/031885 WO2013176764A1 (en) 2012-05-24 2013-03-15 Synthetic and purification methods for phosphaplatin compounds and uses thereof
EP13793812.2A EP2855496B1 (en) 2012-05-24 2013-03-15 Synthetic and purification methods for phosphaplatin compounds and uses thereof

Publications (1)

Publication Number Publication Date
HRP20170416T1 true HRP20170416T1 (hr) 2017-05-19

Family

ID=49624225

Family Applications (2)

Application Number Title Priority Date Filing Date
HRP20170416TT HRP20170416T1 (hr) 2012-05-24 2013-03-15 Sintetski postupci i postupci pročišćavanja spojeva fosfaplatine i njihova uporaba
HRP20191904TT HRP20191904T1 (hr) 2012-05-24 2019-10-21 Postupak pročišćavanja spojeva fosfaplatine

Family Applications After (1)

Application Number Title Priority Date Filing Date
HRP20191904TT HRP20191904T1 (hr) 2012-05-24 2019-10-21 Postupak pročišćavanja spojeva fosfaplatine

Country Status (18)

Country Link
US (2) US8846964B2 (cg-RX-API-DMAC10.html)
EP (2) EP2855496B1 (cg-RX-API-DMAC10.html)
JP (1) JP5833795B2 (cg-RX-API-DMAC10.html)
CN (2) CN106967124B (cg-RX-API-DMAC10.html)
CY (2) CY1118746T1 (cg-RX-API-DMAC10.html)
DK (2) DK3202769T3 (cg-RX-API-DMAC10.html)
ES (2) ES2619412T3 (cg-RX-API-DMAC10.html)
HR (2) HRP20170416T1 (cg-RX-API-DMAC10.html)
HU (2) HUE032197T2 (cg-RX-API-DMAC10.html)
IN (1) IN2014KN02722A (cg-RX-API-DMAC10.html)
LT (2) LT3202769T (cg-RX-API-DMAC10.html)
PL (2) PL2855496T3 (cg-RX-API-DMAC10.html)
PT (2) PT3202769T (cg-RX-API-DMAC10.html)
RS (2) RS59725B1 (cg-RX-API-DMAC10.html)
SI (2) SI3202769T1 (cg-RX-API-DMAC10.html)
SM (2) SMT201900617T1 (cg-RX-API-DMAC10.html)
TW (2) TWI653237B (cg-RX-API-DMAC10.html)
WO (1) WO2013176764A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3202769T1 (sl) * 2012-05-24 2020-02-28 Phosplatin Therapeutics Llc Postopek čiščenja za fosfaplatinove spojine
SG11201808717QA (en) * 2016-04-06 2018-11-29 Phosplatin Therapeutics Llc Phosphaplatin liquid formulations
WO2018129257A1 (en) * 2017-01-06 2018-07-12 Phosplatin Therapeutics Llc Phosphaplatin compounds as therapeutic agents for treatment of bone blood cancers
WO2019051246A1 (en) * 2017-09-08 2019-03-14 Phosplatin Therapeutics Llc PHOSPHAPLATINE COMPOUNDS AS IMMUNOMODULATORS AND THERAPEUTIC USES THEREOF
CN113861036B (zh) * 2021-11-08 2024-04-02 合肥工业大学 一种乙二胺高氯酸铜配合物的制备及用途
US11673904B1 (en) 2021-12-09 2023-06-13 L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Low pressure process for synthesis of Pt(PF3)4 involving a soluble intermediate and storage of obtained Pt(PF3)4
CN119822568B (zh) * 2025-02-19 2025-08-19 扬州宏鑫环保科技有限公司 一种高效纯化水制备装置及制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234500A (en) * 1979-03-07 1980-11-18 Engelhard Minerals & Chemicals Corporation Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
WO2005000858A2 (en) 2003-06-27 2005-01-06 Akira Odani Bisphosphonate complexes
RU2008135369A (ru) * 2006-01-30 2010-03-10 Платко Текнолоджис (Проприэтэри) Лимитед (Za) Получение комплексов платины(ii)
RU2482841C2 (ru) * 2007-05-18 2013-05-27 ТиТиАй Эллебо, Инк. Устройства для трансдермальной доставки, обеспечивающие улучшенное высвобождение действующего начала через биологическую поверхность
WO2009021081A2 (en) 2007-08-06 2009-02-12 Ohio University Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin
DK2575802T3 (en) 2010-06-04 2017-01-09 Univ Ohio Phosphaplatiner and use thereof for the treatment of cancer
US9012669B2 (en) * 2011-10-05 2015-04-21 The University Of Houston System Efficient processes for large scale preparation of phosphaplatins antitumor agents
SI3202769T1 (sl) * 2012-05-24 2020-02-28 Phosplatin Therapeutics Llc Postopek čiščenja za fosfaplatinove spojine

Also Published As

Publication number Publication date
HUE046327T2 (hu) 2020-03-30
HK1203202A1 (en) 2015-10-23
PT3202769T (pt) 2019-10-31
PL2855496T3 (pl) 2017-09-29
CN106967124B (zh) 2020-03-06
EP2855496A4 (en) 2015-04-08
US20140288321A1 (en) 2014-09-25
JP5833795B2 (ja) 2015-12-16
ES2619412T3 (es) 2017-06-26
EP2855496A1 (en) 2015-04-08
HRP20191904T1 (hr) 2020-01-24
LT3202769T (lt) 2019-12-10
IN2014KN02722A (cg-RX-API-DMAC10.html) 2015-05-08
SMT201900617T1 (it) 2020-01-14
SMT201700168T1 (it) 2017-05-08
DK3202769T3 (da) 2019-10-28
SI3202769T1 (sl) 2020-02-28
TWI599361B (zh) 2017-09-21
US20140024848A1 (en) 2014-01-23
CN104540839A (zh) 2015-04-22
WO2013176764A1 (en) 2013-11-28
RS55806B1 (sr) 2017-08-31
PT2855496T (pt) 2017-03-23
US8859796B1 (en) 2014-10-14
EP2855496B1 (en) 2016-12-14
LT2855496T (lt) 2017-04-10
ES2751668T3 (es) 2020-04-01
CN106967124A (zh) 2017-07-21
TWI653237B (zh) 2019-03-11
EP3202769A1 (en) 2017-08-09
TW201741326A (zh) 2017-12-01
SI2855496T1 (sl) 2017-04-26
TW201347765A (zh) 2013-12-01
EP3202769B1 (en) 2019-10-02
JP2015523335A (ja) 2015-08-13
HUE032197T2 (en) 2017-09-28
PL3202769T3 (pl) 2020-03-31
DK2855496T3 (en) 2017-03-27
US8846964B2 (en) 2014-09-30
CY1122316T1 (el) 2021-01-27
CY1118746T1 (el) 2018-03-07
CN104540839B (zh) 2017-02-22
RS59725B1 (sr) 2020-01-31

Similar Documents

Publication Publication Date Title
HRP20170416T1 (hr) Sintetski postupci i postupci pročišćavanja spojeva fosfaplatine i njihova uporaba
HRP20140808T1 (hr) Fosfaplatine i njihova uporaba za lijeäśenje raka rezistentnog na cisplantin i karboplatin
HRP20201847T1 (hr) Postupak za pripremu spoja diariltiohidantoina
CN102481513A (zh) 用于气体吸着的离子液体和装置的使用方法
JP2014154178A5 (cg-RX-API-DMAC10.html)
HRP20180976T1 (hr) Inhibitori iap
AR048008A1 (es) Procesos para la preparacion de inhibidores de caspasa derivados de los mismos
CN103951582A (zh) 一种乙酰乙酰苯胺类化合物的制备方法
CN102531989B (zh) 一种(s)-奥拉西坦的纯化方法
HRP20161145T1 (hr) Postupak za pripravu l-argininske soli perindoprila
NO20080768L (no) Fremgangsmate for fremstilling av 5-aminolevulinsyre-hydroklorid
TW201706035A (zh) 逆滲透膜用洗淨劑、洗淨液及洗淨方法
CN103254660B (zh) 一种不含尿素的二磺酸三嗪基类荧光增白剂液体的制备方法
CN102531988A (zh) 一种左旋奥拉西坦的纯化方法
HRP20180948T1 (hr) Postupak za proizvodnju aminokiselinskih spojeva
CN105037288B (zh) 一种布醇的制备方法
CN103288857B (zh) 沙拉沙星金属配合物及其制备方法
Zhou et al. Chiral resolution of DL‐glutamic acid by a chiral additive
HRP20141023T1 (hr) Novi postupak sinteze ivabradina i njegovih adicijskih soli sa farmaceutski prihvatljivom kiselinom
Soliman et al. Synthesis of novel modified guanidines: reaction of dicyandiamide with amino acids, amides, and amines in aqueous medium
HRP20140942T1 (hr) Postupak pripreme kontrastnih sredstava
RU2009128063A (ru) Способ получения и выделения отдельных стереоизомеров 1-амино, 3-замещенных фенилциклопентанекарбоксилатов
CN102976881B (zh) 一种联苯的制备方法
JP6126102B2 (ja) 純粋なS−(−)−9−フルオロ−6,7−ジヒドロ−8−(4−ヒドロキシピペリジン−1−イル)−5−メチル−1−オキソ−1H,5H−ベンゾ[i,j]キノリジン−2−カルボン酸L−アルギニン塩4水和物およびその製造方法
HRP20140839T1 (hr) Postupak sinteze ivabradina i njegovih adicijskih soli i farmaceutski prihvatljivih kiselina